- Home
- VCIC vs VNDA Comparison
VCIC vs VNDA Comparison
Compare VCIC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIC
- VNDA
- Stock Information
- Founded
- VCIC 2024
- VNDA 2002
- Country
- VCIC United States
- VNDA United States
- Employees
- VCIC N/A
- VNDA N/A
- Industry
- VCIC
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- VCIC
- VNDA Health Care
- Exchange
- VCIC NYSE
- VNDA Nasdaq
- Market Cap
- VCIC 297.4M
- VNDA 282.8M
- IPO Year
- VCIC 2024
- VNDA 2006
- Fundamental
- Price
- VCIC $10.15
- VNDA $4.78
- Analyst Decision
- VCIC
- VNDA Strong Buy
- Analyst Count
- VCIC 0
- VNDA 2
- Target Price
- VCIC N/A
- VNDA $16.50
- AVG Volume (30 Days)
- VCIC 1.4K
- VNDA 652.5K
- Earning Date
- VCIC 01-01-0001
- VNDA 05-07-2025
- Dividend Yield
- VCIC N/A
- VNDA N/A
- EPS Growth
- VCIC N/A
- VNDA N/A
- EPS
- VCIC N/A
- VNDA N/A
- Revenue
- VCIC N/A
- VNDA $198,772,000.00
- Revenue This Year
- VCIC N/A
- VNDA $14.36
- Revenue Next Year
- VCIC N/A
- VNDA $44.53
- P/E Ratio
- VCIC N/A
- VNDA N/A
- Revenue Growth
- VCIC N/A
- VNDA 3.18
- 52 Week Low
- VCIC $9.96
- VNDA $3.71
- 52 Week High
- VCIC $10.16
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- VCIC N/A
- VNDA 48.67
- Support Level
- VCIC N/A
- VNDA $4.84
- Resistance Level
- VCIC N/A
- VNDA $5.04
- Average True Range (ATR)
- VCIC 0.00
- VNDA 0.22
- MACD
- VCIC 0.00
- VNDA -0.01
- Stochastic Oscillator
- VCIC 0.00
- VNDA 26.32
About VCIC VINE HILL CAP INVT CORP
Vine Hill Capital Investment Corp is a blank check company.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.